三生国健: 三生国健药业（上海）股份有限公司信息披露管理办法

Core Viewpoint - The document outlines the information disclosure management measures for Sanofi Health Industry (Shanghai) Co., Ltd., emphasizing the importance of timely, accurate, and complete information disclosure to protect the rights of shareholders and the public [1]. Group 1: General Principles of Information Disclosure - The company must disclose all information that could significantly impact the trading price of its stocks or investment decisions [6][7]. - Information must be disclosed in a timely, fair, and accurate manner, ensuring clarity and avoiding misleading statements [7][8]. - All investors should have equal access to disclosed information, preventing selective disclosure [11]. Group 2: Responsibilities and Obligations - The chairman of the board is the primary responsible person for information disclosure, while the board secretary is responsible for its execution [2]. - All related parties, including directors, senior management, and shareholders, have disclosure obligations [2][3]. - The company must ensure that any public commitments made by related parties are disclosed promptly [3]. Group 3: Disclosure of Major Events - Major events must be disclosed immediately upon the board's resolution or when relevant parties sign agreements [12]. - If a major event is uncertain, the company may delay disclosure but must do so at the latest when a final decision is made [12]. - The company must disclose any significant changes to previously disclosed matters that could impact stock prices [14]. Group 4: Content of Disclosure - The company must disclose information reflecting its business, technology, finance, governance, competitive advantages, industry trends, and policy impacts [6]. - Regular disclosures should include annual, semi-annual, and quarterly reports, detailing financial data and significant events [30][31]. - The company must provide detailed explanations for any significant declines in net profit or revenue [26]. Group 5: Industry Information and Risks - The company should proactively disclose industry information that could significantly affect stock prices or investor decisions [59]. - It must identify and disclose risks that could adversely impact its core competitiveness and operational activities [64][65]. - Any major changes in the industry environment or operational risks must be disclosed promptly [67].